Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
Yutaka Seino; Yasuo Terauchi; Takeshi Osonoi; Daisuke Yabe; Nobuyuki Abe; Tomoyuki Nishida; Jeppe Zacho; Shizuka Kaneko
Author Information: Kansai Electric Power Medical Research Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.